Zynerba's cannabis-based gel succeeds in mid-stage study

Sept 28 (Reuters) - Zynerba Pharmaceuticals Inc said on Thursday its cannabis-based gel succeeded in a mid-stage study of patients with Fragile X ...

read more here
Delivered by @can_nab_is